Records containing: Multiple Myeloma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2017-01-11A Phase 2 Single Arm Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients
-
CLINICAL_TRIALS study record update · 2017-01-05Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Relapsed or Refractory Multiple Myeloma (MM)
-
CLINICAL_TRIALS study record update · 2016-12-22Pilot Study of recMAGE-A3 + AS15 ASCI as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2016-12-20Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies: High-dose Cyclophosphamide Versus Plerixafor
-
CLINICAL_TRIALS study record update · 2016-12-09A Single Institution, Open-Label, Nonrandomized Pilot Study of High Dose Epoetin Alfa Administered Once a Week in Patients With Multiple Myeloma: Its Effects on Hemoglobin, Blood Transfusion Requirements and Quality of Life
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-12-05A Double-blind Phase 2 Study to Assess the Safety and Efficacy of Aloxi (Palonosetron HCl) for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving High-dose Melphalan as Conditioning Chemotherapy for Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2016-12-05Phase 1 Clinical Trial to Evaluate Security and Dose of Expanded and Activated Autologous NK Cells Infusions in Consolidation of Multiple Myeloma Patients Treatment on Second or Later Relapse.
-
CLINICAL_TRIALS study record update · 2016-12-02Research Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions
-
CLINICAL_TRIALS study record update · 2016-12-01A Phase I Study of DVd +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM)
-
CLINICAL_TRIALS study record update · 2016-11-17A Phase II Study of Eltrombopag for the Treatment of Thrombocytopenia in Patients Undergoing Therapy for Relapsed Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-11-08A Randomized, Triple-arm, Controlled, Open-label, Multicenter Phase II Study Assessing Two Different Doses of Panobinostat in Combination With Carfilzomib and Dexamethasone in Relapsed or Relapsed and Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-11-02An Open-label, Multicenter, Phase I Trial of the Safety and Pharmacokinetics of Escalating Doses of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-11-02A Multicenter, Single-arm, Open-label Study to Evaluate the Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-11-02An Open-Label, Multicenter, Phase I Trial of the Safety and Pharmacokinetics of Escalating Doses of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-10-31A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects
-
CLINICAL_TRIALS study record update · 2016-10-28A Phase II, Safety and Efficacy Study of Fixed Dose Radioimmunotherapy (Zevalin, Yttrium-90 Ibritumomab Tiuxetan) for Patients With Incomplete Response to Chemotherapy Prior to Autologous Stem Cell Transplant for Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-10-20SEIFEM 2015: Fungemia in Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2016-10-18Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant
-
CLINICAL_TRIALS study record update · 2016-10-17Phase II Open Label Study for the Assessment of the Efficacy and Safety of Lenalidomide & Adriamycin & Low Dose Dexamethasone (RAD) in Newly Diagnosed, Symptomatic Multiple Myeloma Patients
-
CLINICAL_TRIALS study record update · 2016-10-11ClinicalTrials.gov study NCT00779922
-
CLINICAL_TRIALS study record update · 2016-10-07A Phase 1b/2 Trial to Evaluate the Safety and Efficacy of Radium-223 Dichloride (BAY88-8223) in Combination With Bortezomib and Dexamethasone in Early Relapsed Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-10-07S0120, A Prospective Observational Biologic Study of Asymptomatic Patients With Monoclonal Gammopathy and Plasmaproliferative Disorders
-
CLINICAL_TRIALS study record update · 2016-10-06Phase I Clinical Trial to Assess the Safety and Pharmacokinetic Profile of CKD-581 in Patients With Lymphoma or Multiple Myeloma Failed to Standard Therapy
-
CLINICAL_TRIALS study record update · 2016-10-06An Open-label Trial to Collect Long-term Data on Subjects Following Participation in Previous EMD 531444 (L-BLP25 or BLP25 Liposome Vaccine) Clinical Trials
-
CLINICAL_TRIALS study record update · 2016-10-05European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy